Our progress developing ABS-201 for androgenetic alopecia is ahead of plan as we expect to initiate a phase 1/2a trial in ...
Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society ...
Dates: Thursday, May 14, 2026 Time: 5:30–10:00 PM Where: Four Points by Sheraton Link: Event Link Details: Celebrate and ...
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...
Most students in Simcoe County, including those in Barrie, Orillia, Collingwood and Wasaga Beach, have a PA Day on Friday, ...
Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.
After months of growing concern from teachers and parents, Alberta’s government is turning to collaboration to tackle classroom overcrowding and rising complexity. Premier Danielle Smith has announced ...
STOCKHOLM – 14 November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website.
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...
State-of-the-art single-cell RNA sequencing and proteomics approaches were employed to benchmark porcine and human pancreatic ...